Patent Assignment
Reel/Frame 056476/0162
Change of Name
Recorded: 2021-06-03
Pages: 4
Assignor
MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Executed: 2020-06-16
Assignee
MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
COLLEGE BUSINESS AND TECHNOLOGY PARK, CRUISERATH ROAD, BLANCHARDSTOWN, DUBLIN, 15, IRELAND
Covered Properties
(28)
Systems And Methods for Compensating Long Term Sensitivity Drift Of Electrochemical Gas Sensors Exposed to Nitric Oxide
Administration and Monitoring of Nitric Oxide in Ex Vivo Fluids
Method for Ex-Vivo Expansion of Regulatory T Cells with Enhanced Suppressive Function for Clinical Application in Immune Mediated Diseases
Use and Monitoring of Inhaled Nitric Oxide with Left Ventricular Assist Devices
Methods to Improve Organ Viability
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Gas Delivery Device and System for Use in Magnetic Resonance Imaging
Systems and Method for Delivery of Therapeutic Gas to Patients in Need Thereof Using Enhanced Breathing Circuit Gas (Bcg) Flow Measurement
Systems and Method for Delivery of Therapeutic Gas to Patients in Need Thereof Using Enhanced Breathing Circuit Gas (Bcg) Flow Measurement
Devices and Methods for Monitoring Oxygenation Uring Treatment with Delivery of Nitric Oxide
Application:
16/365,263 →
Publication:
US 2019/0216377
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
16/411,944 →
Publication:
US 2019/0328831
Systems and Methods for Manufacturing and Safety of an NO2-to-No Reactor Cartridge Used to Deliver No for Inhalation Therapy to a Patient
Apparatus and Method for Monitoring Nitric Oxide Delivery
Compensating for Disruptions in Breathing Gas Flow Measurement
Apparatus and Method for Humidity Conditioning Sample Gas of a Patient Breathing Circuit Affiliated with a Ventilator and/or Nitric Oxide Delivery System
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
16/669,151 →
Publication:
US 2020/0046798
Clinical Decision Support System and Methods
Systems and Methods for Indicating Lifetime of an NO2-to-No Reactor Cartridge Used to Deliver No for Inhalation Therapy to a Patient
Enhanced Performance Verification Port for Therapeutic Gas Delivery
Apparatus and Method for Detecting Liquid Level in a Clear or Partially Clear Container
Systems and Methods for Delivery of Therapeutic Gas
Method of Identifying and Treating Premature Infants at Risk for Bpd
Intelligent Gas Source Management
Systems and Methods for Intelligent Gas Source Management
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
16/828,674 →
Publication:
US 2020/0246418
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
16/828,681 →
Publication:
US 2020/0237856
Administration and Monitoring of Nitric Oxide in Ex Vivo Fluids
Apparatus and Method for Filtering Liquid Particles from Inspiratory Gas Flow of a Patient Breathing Circuit Affiliated with a Ventilator and/or Nitric Oxide Delivery System
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 12, 2019
From: POTENZIANO, JIM; GREENE, DOUGLAS ALAN; FLANAGAN, CRAIG
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 049742/0315 →
Notice of Grant of Security Interest in Intellectual Property
Jul 22, 2019
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 049822/0674 →
Nunc Pro Tunc Assignment
Aug 14, 2019
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 050056/0042 →
Nunc Pro Tunc Assignment
Aug 14, 2019
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 050056/0303 →
Nunc Pro Tunc Assignment
Aug 14, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP
Reel/Frame 050056/0219 →
Nunc Pro Tunc Assignment
Aug 14, 2019
From: MALLINCKRODT CRITICAL CARE FINANCE INC.
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 050056/0122 →
Assignment of Assignor's Interest
Oct 31, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP
Reel/Frame 050900/0039 →
Assignment of Assignor's Interest
Oct 31, 2019
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 050883/0398 →
Assignment of Assignor's Interest
Oct 31, 2019
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE, INC.
Reel/Frame 050883/0298 →
Assignment of Assignor's Interest
Oct 31, 2019
From: MALLINCKRODT HOSPITAL PRODUCTS INC.
To: THERAKOS, INC.
Reel/Frame 050883/0254 →
Change of Name
Oct 31, 2019
From: IKARIA THERAPEUTICS LLC
To: MALLINCKRODT HOSPITAL PRODUCTS INC.
Reel/Frame 050883/0201 →
Assignment of Assignor's Interest
Oct 31, 2019
From: JAMIL, KHURRAM; PAPPAS, STEPHEN CHRIS; POTENZIANO, JIM
To: IKARIA THERAPEUTICS LLC
Reel/Frame 050899/0925 →
Assignment of Assignor's Interest
Oct 31, 2019
From: MALLINCKRODT CRITICAL CARE FINANCE, INC.
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 050900/0060 →
Notice of Grant of Security Interest in Intellectual Property
Dec 9, 2019
From: MALLINCKRODT LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 051231/0961 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Assignment of Assignor's Interest
Feb 14, 2020
From: POTENZIANO, JIM
To: MALLINCKRDOT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 051822/0983 →
Notice of Grant of Security Interest in Intellectual Property
Apr 21, 2020
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 052456/0158 →
Security Interest
Apr 22, 2020
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; OCERA THERAPEUTICS, INC.; ST SHARED SERVICES LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 052463/0396 →
Assignment of Assignor's Interest
Jun 3, 2021
From: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 056433/0640 →
Security Interest
Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Release of Security Interest
Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Notice of Grant of Security Interest in Intellectual Property
Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Security Interest
Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Security Interests in Patents at Reel 060389/Frame 0913
Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Release of Patent Security Interests Recorded at Reel 043601, Frame 0025
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0233 →